William Blair on Sage Therapeutics (SAGE): 'we have difficulty envisioning what additional data could be generated to support a resubmission'

Go back to William Blair on Sage Therapeutics (SAGE): 'we have difficulty envisioning what additional data could be generated to support a resubmission'

Form 8-K Sage Therapeutics, Inc. For: Apr 17

April 17, 2024 6:36 AM EDT

DE false 0001597553 0001597553... More